Welcome
Support Centre
09 January 2009 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Efficacy of metoprolol CR/XL on diabetic postoperative mortality and cardiovascular morbidity: a randomised, double blind, placebo-controlled, multicentre trial
ISRCTN ISRCTN58485613
ClinicalTrials.gov identifier
Public title Efficacy of metoprolol CR/XL on diabetic postoperative mortality and cardiovascular morbidity: a randomised, double blind, placebo-controlled, multicentre trial
Scientific title
Acronym DIPOM
Serial number at source Not Applicable
Study hypothesis Not provided at time of registration
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment Denmark
Disease/condition/study domain Diabetes mellitus and major surgery
Participants - inclusion criteria Patients 40 years of age with diabetes undergoing noncardiac major (lasting more than 1 hour) surgery
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/07/2000
Anticipated end date 01/07/2002
Status of trial Completed
Patient information material
Target number of participants Not provided at time of registration
Interventions Diabetic patients undergoing major noncardiac surgery are randomised to 7 days of perioperative beta blocking (Metoprolol CR/XL [SeloZok®] 100 mg daily) versus placebo treatment.
Primary outcome measure(s) Not provided at time of registration
Secondary outcome measure(s) Not provided at time of registration
Sources of funding 1. The Danish Heart Foundation (Denmark) (ref: 01-2-5-51A-22931)
2. The Danish Diabetes Foundation (Denmark) (ref: C.1)
3. The Copenhagen Hospital Corporation's Research Council (Denmark) (ref: 109/01)
4. Programme for Strengthening Regional Collaboration within Medical Health Research (Denmark) (ref: 301-070-5199)
5. AstraZeneca (Denmark) (ref: AD-MET-0003)
Trial website
Publications Results in http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16793810
Contact name Dr  Anne Benedicte  Juul
  Address Copenhagen Trial Unit
Centre for Clinical Intervention Research
H:S Rigshospitalet
Dept 7102
  City/town Copenhagen Ø
  Zip/Postcode DK-2100
  Country Denmark
  Tel +45 3545 7156 or +45 3526 7235
  Fax +45 3545 7101
  Email Anne.j@ctu.rh.dk
Sponsor Copenhagen Trial Unit (Denmark)
  Address Centre for Clinical Intervention Research
H:S Rigshospitalet
Dept 7102
  City/town Copenhagen Ø
  Zip/Postcode DK-2100
  Country Denmark
Date applied 27/02/2002
Last edited 06/09/2007
Date ISRCTN assigned 27/02/2002
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central